Skip to Main Content

Paper Details

Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.
Nat Commun
1
2023
Author NameAffiliation
Alexandra DanyiCenter for Molecular Medicine, University Medical Center Utrecht
Job van RietErasmus MC Cancer Institute
Ronald de WitErasmus MC Cancer Institute
Martin Sj??str??mUniversity of California san francisco
Felix Y FengUniversity of California san francisco
Jeroen de RidderCenter for Molecular Medicine, University Medical Center Utrecht
Martijn P LolkemaErasmus MC Cancer Institute
  • 1 - 7

Datasets

Release 1.2